Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,062 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
ESGO-ESMO-ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent disease.
Ledermann JA, Matias-Guiu X, Amant F, Concin N, Davidson B, Fotopoulou C, González-Martin A, Gourley C, Leary A, Lorusso D, Banerjee S, Chiva L, Cibula D, Colombo N, Croce S, Eriksson AG, Falandry C, Fischerova D, Harter P, Joly F, Lazaro C, Lok C, Mahner S, Marmé F, Marth C, McCluggage WG, McNeish IA, Morice P, Nicum S, Oaknin A, Pérez-Fidalgo JA, Pignata S, Ramirez PT, Ray-Coquard I, Romero I, Scambia G, Sehouli J, Shapira-Frommer R, Sundar S, Tan DSP, Taskiran C, van Driel WJ, Vergote I, Planchamp F, Sessa C, Fagotti A. Ledermann JA, et al. Among authors: scambia g. Ann Oncol. 2024 Mar;35(3):248-266. doi: 10.1016/j.annonc.2023.11.015. Epub 2024 Feb 1. Ann Oncol. 2024. PMID: 38307807
Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) Applied to Platinum-Resistant Recurrence of Ovarian Tumor: A Single-Institution Experience (ID: PARROT Trial).
Vizzielli G, Giudice MT, Nardelli F, Costantini B, Salutari V, Inzani FS, Zannoni GF, Chiantera V, Di Giorgio A, Pacelli F, Fagotti A, Scambia G. Vizzielli G, et al. Among authors: scambia g. Ann Surg Oncol. 2024 Feb;31(2):1207-1216. doi: 10.1245/s10434-023-14648-0. Epub 2023 Dec 15. Ann Surg Oncol. 2024. PMID: 38099993 Free PMC article.
Assessing the pathogenicity of BRCA1/2 variants of unknown significance: Relevance and challenges for breast cancer precision medicine.
De Paolis E, Paris I, Tilocca B, Roncada P, Foca L, Tiberi G, D'Angelo T, Pavese F, Muratore M, Carbognin L, Garganese G, Masetti R, Di Leone A, Fabi A, Scambia G, Urbani A, Generali D, Minucci A, Santonocito C. De Paolis E, et al. Among authors: scambia g. Front Oncol. 2023 Jan 18;12:1053035. doi: 10.3389/fonc.2022.1053035. eCollection 2022. Front Oncol. 2023. PMID: 36741700 Free PMC article.
Editorial: Methods in gynecological oncology.
Perelli F, Mattei A, Scambia G, Cavaliere AF. Perelli F, et al. Among authors: scambia g. Front Oncol. 2023 Mar 9;13:1167088. doi: 10.3389/fonc.2023.1167088. eCollection 2023. Front Oncol. 2023. PMID: 36969075 Free PMC article. No abstract available.
Primary flap closure of perineal defects to avoid empty pelvis syndrome after pelvic exenteration in gynecologic malignancies: An old question to explore a new answer.
Arcieri M, Restaino S, Rosati A, Granese R, Martinelli C, Caretto AA, Cianci S, Driul L, Gentileschi S, Scambia G, Vizzielli G, Ercoli A. Arcieri M, et al. Among authors: scambia g. Eur J Surg Oncol. 2024 Feb;50(2):107278. doi: 10.1016/j.ejso.2023.107278. Epub 2023 Dec 18. Eur J Surg Oncol. 2024. PMID: 38134482 Free article. Review.
[No title available]
[No authors listed] [No authors listed] PMID: 39249002
[No title available]
[No authors listed] [No authors listed] PMID: 39249260
2,062 results